On October 8, DF/HCC's William Kaelin, MD, and David Scadden, MD, were announced as two of the 65 new appointments to the Institute of Medicine

Aisha Townes spoke with such authority on the topic of antibody biomarkers in cancer detection that it would be easy to think she had studied the subject for years, not weeks

The research efforts of the Dana-Farber/Harvard Cancer Center SPORE in Ovarian Cancer were honored on Thursday, September 20th at the Omni Parker House in Boston

DF/HCC Members Levi Garraway MD, PhD, and Mark Johnson, MD, PhD, were recently announced by the NIH as 2007 recipients of the NIH Director's New Innovator Award

Like a clever chess player, cancer has evolved strategies to escape capture by its opponent, the immune system—a coordinated network of specialized cells that normally protects the body against attacks from foreign invaders

Since 1947, when Sidney Farber, MD, achieved the first remission of acute pediatric leukemia, Children’s Hospital Boston has blazed the trail leading to higher survival rates for childhood cancers